Cite

HARVARD Citation

    Dörner, T. et al. (n.d.). OP0045 DELINEATION OF A PROINFLAMMATORY CYTOKINE PROFILE TARGETED BY JAK1/2 INHIBITION USING BARICITINIB IN A PHASE 2 SLE TRIAL. Annals of the rheumatic diseases. pp. 29-30. [Online]. 
  
Back to record